Compression stockings for preventing deep vein thrombosis in airline passengers

Are these interventions genuinely effective? The verdict lies within a meticulous research published in the Cochrane Database of Systematic Reviews. The authors of this study undertook a comprehensive investigation to unravel the efficacy of compression stockings use in contrast to abstaining from their use, with the intent of averting Deep Vein Thrombosis (DVT) among individuals on flights of no less than 4 hours. This comprehensive review included 9 trials, with a cumulative group of 2637 participants.
Deep vein thrombosis, an affliction characterized by a partial or complete obstruction within the body's deep venous system owing to the formation of blood clots, predominantly manifests within the lower extremities. The clinical indicators of DVT, oftentimes marked by a delayed onset, can prove diagnostically challenging. Historical records trace the inception of venous thrombosis attributed to air travel back to 1954, a case involving a 54-year-old physician who got DVT following a 14-hour flight. Two main factors have been proposed to cause DVT risk— traveling (prolonged immobilization) and individual predisposition (heritable or acquired clotting disorders, advanced age, recent surgical interventions, or trauma).
The outcomes of this study unequivocally assert the tangible impact associated with the use of stockings as opposed to their absence. This effect suggest an approximate 90% reduction in the likelihood of symptomless DVT occurrences. Furthermore, a substantial diminution in leg edema—a hallmark concomitant of stockings utilization—is also noted. These findings bestow valuable insights into the realm of DVT prevention, presenting compression stockings as a potent ally in mitigating associated risks.